Keith M. Gregg - Concepedia

Concepedia

Author

Keith M. Gregg

Janssen (United States)

Also Known As

Keith Gregg, Keith M Gregg, Keith M. Gregg, Keith M. Gregg, MS

26

Publications

2.6K

Citations

14

H-Index

40

Concepts

All Affiliations

Janssen (United States)Stanford University Pfizer (United States)Palo Alto Veterans Institute for Research University College London

KM

About

Keith M. Gregg is an author at Janssen (United States) specializing in medicine, anesthesia, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.7K
2	Anesthesia	3	3	176
3	Health Sciences	1	1	28
4	Social Sciences	1	1	14
5	Biomedical Engineering	1	1	256

Keith M. Gregg

×

17

Publications

2.6K

Citations

14

H-Index

	Year	Citations
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study Juha O. Rinne, David J. Brooks, Martin N. Rossor, The Lancet Neurology Neurodegenerative DiseasesAscending-dose StudyAlzheimer's Disease11C-pib Pet AssessmentBiomarkers	2010	694
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis Reisa A. Sperling, Stephen Salloway, David J. Brooks, The Lancet Neurology Alzheimer's DiseaseDementiaRetrospective AnalysisVascular DementiaFrontotemporal Dementia	2012	497
Response Surface Model for Anesthetic Drug Interactions Charles F. Minto, Thomas W. Schnider, Timothy G. Short, Anesthesiology	2000	352
Algorithms to rapidly achieve and maintain stable drug concentrations at the site of drug effect with a computer-controlled infusion pump Steven L. Shafer, Keith M. Gregg Journal of Pharmacokinetics and Biopharmaceutics Therapeutic Drug MonitoringDrug EffectMedicineStable Drug ConcentrationsPharmaceutical Technology	1992	256
Using the Time of Maximum Effect Site Concentration to Combine Pharmacokinetics and Pharmacodynamics Charles F. Minto, Thomas W. Schnider, Keith M. Gregg, Anesthesiology	2003	160
Amyloid-β <sup>11</sup> C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials Enchi Liu, Mark E. Schmidt, Richard Margolin, Neurology	2015	149
Preoperative Anxiety and Fear Audrey Shafer, M. Pamela Fish, Keith M. Gregg, Anesthesia & Analgesia Primary CarePatient SafetyPostoperative ConsiderationPost-operative CareOutcomes Research	1996	86
Preoperative Anxiety and Fear Audrey Shafer, M. Pamela Fish, Keith M. Gregg, Anesthesia & Analgesia Primary CarePatient SafetyPostoperative ConsiderationPost-operative CareOutcomes Research	1996	76
Vascular alterations in PDAPP mice after anti‐Aβ immunotherapy: Implications for amyloid‐related imaging abnormalities Wagner Zago, Sally Schroeter, Teresa Guido, Alzheimer s & Dementia	2013	70
Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer’s Disease Gerald Novak, Nick C. Fox, Shona Clegg, Journal of Alzheimer s Disease	2015	58

Page 1